Search Results

You are looking at 131 - 140 of 2,734 items for :

  • Refine by Access: All x
Clear All
Full access

Management of Patients With Lung Cancer and Poor Performance Status

Ajeet Gajra, Alissa S. Marr, and Apar Kishor Ganti

patient populations that respond differently to treatment and have different outcomes. 7 Another challenge in interpreting the trial evidence for this group of patients is the subjectivity associated with assigning a PS to any given patient. A recent

Full access

New Treatment Guidelines for Penile Cancer

Philippe E. Spiess

NCCN Panel on bladder and penile cancers. With the use of non–evidence-based treatment approaches, outcomes can widely vary. To clarify some of the controversies associated with the treatment of penile cancer, NCCN has created inaugural NCCN Clinical

Full access

Neoadjuvant Therapy for Rectal Cancer Affects Lymph Node Yield and Status Without Clear Implications on Outcome: The Case for Eliminating a Metric and Using Preoperative Staging to Guide Therapy

Sherif R. Z. Abdel-Misih, Lai Wei, Al B. Benson III, Steven Cohen, Lily Lai, John Skibber, Neal Wilkinson, Martin Weiser, Deborah Schrag, and Tanios Bekaii-Saab

Background Nodal status has long been considered a key pathologic factor in cancer management and care. Previous studies have demonstrated an association between lymph node yield and status with regard to patient outcomes in colorectal cancer

Full access

Improving Health Equity and Reducing Disparities in Pediatric and Adolescent/Young Adult Oncology: In Support of Clinical Practice Guidelines

Justine M. Kahn and Melissa Beauchemin

, adolescents, and young adults (AYA; aged 15–39 years) with HL exceed 95%, with event-free survival (EFS) rates >85%. 4 The treatment successes in HL are attributed, in part, to 4 key factors: (1) research to identify disease-related predictors of poor outcome

Full access

Advances in the Care of Adult Patients With Acute Lymphoblastic Leukemia: Optimism Tempered by Reality

Joseph C. Alvarnas and Patrick A. Brown

Outcomes for patients with acute lymphoblastic leukemia (ALL) have improved dramatically over the past 4 decades. Overall 5-year relative survival rates for patients with ALL have increased from 40.6% during the period between 1975 and 1977 to 70

Full access

Feasibility and Effectiveness of Self-Management Education and Coaching on Patient Activation for Managing Cancer Treatment Toxicities

Doris Howell, Gregory R. Pond, Denise Bryant-Lukosius, Melanie Powis, Patrick T. McGowan, Tutsirai Makuwaza, Vishal Kukreti, Sara Rask, Saidah Hack, and Monika K. Krzyzanowska

also examined preliminary estimates of effectiveness based on patient-reported outcomes. Methods Participants and Recruitment Procedures Ethics approval was obtained from the Ontario Cancer Research Ethics Board for all participating sites

Full access

Identification and Characterization of Avoidable Hospital Admissions in Patients With Lung Cancer

Eric M. Lander, Xuanyi Li, Li-Ching Huang, Amanda S. Cass, Wade T. Iams, Emily A. Skotte, Jennifer G. Whisenant, Robert A. Ramirez, Sally J. York, Travis J. Osterman, Jennifer A. Lewis, Christine M. Lovly, Yu Shyr, and Leora Horn

associated with better outcomes or within patients’ goals of care. Hospital stays in patients with cancer are generally 1.5 days longer and carry a 2-fold higher risk of in-hospital mortality compared with inpatient admissions for other conditions. 6 Most

Full access

Wealth, Health Expenditure, and Cancer: A National Perspective

Jad Chahoud, Adele Semaan, and Alyssa Rieber

Background The health care system in the United States is characterized by an unsustainable increase in spending with penultimate outcomes. 1 , 2 In 2013, the United States spent a total of $2.9 trillion on health, which is approximately $9

Full access

Outpatient Management of Pulmonary Embolism in Cancer: Data on a Prospective Cohort of 138 Consecutive Patients

Carme Font, Alberto Carmona-Bayonas, Aranzazu Fernández-Martinez, Carmen Beato, Andrés Vargas, Pere Gascon, and Remedios Otero

spectrum of PE may vary from sudden life-threatening events to unsuspected radiologic findings on scheduled CT scans. 2 , 3 In several series of patients with acute symptomatic PE, cancer has been identified as a predictor for adverse outcomes. 4 , 5

Full access

Changes in Management of Left-Sided Obstructive Colon Cancer: National Practice and Guideline Implementation

Joyce Valerie Veld, Femke Julie Amelung, Wernard Aat Antoine Borstlap, Emo Eise van Halsema, Esther Catharina Josephina Consten, Peter Derk Siersema, Frank ter Borg, Edwin Silvester van der Zaag, Paul Fockens, Willem Adrianus Bemelman, Jeanin Elise van Hooft, Pieter Job Tanis, and for the Dutch Snapshot Research Group

-term outcomes with additional procedural and long-term surgical and oncologic data through chart review using a web-based tool meeting Dutch privacy regulations by Medical Research Data Management. All 77 Dutch hospitals that register patients in the DCRA were